DK166343C - Forbedret piroxicamholdigt laegemiddel - Google Patents

Forbedret piroxicamholdigt laegemiddel

Info

Publication number
DK166343C
DK166343C DK468486A DK468486A DK166343C DK 166343 C DK166343 C DK 166343C DK 468486 A DK468486 A DK 468486A DK 468486 A DK468486 A DK 468486A DK 166343 C DK166343 C DK 166343C
Authority
DK
Denmark
Prior art keywords
improved
containing medicine
piroxicam
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
DK468486A
Other languages
Danish (da)
English (en)
Other versions
DK468486A (da
DK166343B (da
DK468486D0 (da
Inventor
Thomas Charles Crawford
David Lee Larson
Joseph George Lombardino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK468486D0 publication Critical patent/DK468486D0/da
Publication of DK468486A publication Critical patent/DK468486A/da
Publication of DK166343B publication Critical patent/DK166343B/da
Application granted granted Critical
Publication of DK166343C publication Critical patent/DK166343C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DK468486A 1985-10-02 1986-10-01 Forbedret piroxicamholdigt laegemiddel DK166343C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8501926 1985-10-02
US8501926 1985-10-02

Publications (4)

Publication Number Publication Date
DK468486D0 DK468486D0 (da) 1986-10-01
DK468486A DK468486A (da) 1987-04-03
DK166343B DK166343B (da) 1993-04-13
DK166343C true DK166343C (da) 1993-09-06

Family

ID=22188870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK468486A DK166343C (da) 1985-10-02 1986-10-01 Forbedret piroxicamholdigt laegemiddel

Country Status (15)

Country Link
US (1) US4994457A (fr)
EP (1) EP0218453B1 (fr)
JP (1) JPS6296424A (fr)
KR (1) KR890001236B1 (fr)
AT (1) ATE49121T1 (fr)
AU (1) AU563822B2 (fr)
CA (1) CA1273875A (fr)
DE (1) DE3667914D1 (fr)
DK (1) DK166343C (fr)
GR (1) GR3000305T3 (fr)
HU (1) HU207219B (fr)
IE (1) IE58635B1 (fr)
NZ (1) NZ217778A (fr)
PT (1) PT83472B (fr)
ZA (1) ZA867494B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
JP2002504514A (ja) 1998-02-27 2002-02-12 ニュートラマックス ラボラトリーズ，インコーポレイテッド 肝臓傷害の予防、治療及び修復のためのｌ−エルゴチオネイン、ノゲシ及びｓ−アデノシルメテオニン
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
WO2006030980A1 (fr) * 2004-09-17 2006-03-23 Ajinomoto Co., Inc. Agent et aliment pour la prevention/l'amelioration du trouble digestif fonctionnel
KR101821050B1 (ko) 2015-10-14 2018-03-09 씨제이제일제당 (주) 바이오-기반 n-아세틸-l-메티오닌 및 이의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (fr) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention des lesions gastriques
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
GB2078738B (en) * 1980-06-27 1983-11-30 Mitsui Toatsu Chemicals Benzothiazine derivatives
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4551452A (en) * 1983-12-21 1985-11-05 Pfizer Inc. Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
EP0178122B1 (fr) * 1984-10-11 1991-06-05 Pfizer Inc. Compositions anti-inflammatoires contenant du piroxicame
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
AU563822B2 (en) 1987-07-23
EP0218453A1 (fr) 1987-04-15
CA1273875A (fr) 1990-09-11
HU207219B (en) 1993-03-29
HUT46216A (en) 1988-10-28
GR3000305T3 (en) 1991-06-07
IE58635B1 (en) 1993-10-20
JPH0470285B2 (fr) 1992-11-10
KR870003783A (ko) 1987-05-04
US4994457A (en) 1991-02-19
JPS6296424A (ja) 1987-05-02
EP0218453B1 (fr) 1990-01-03
DK468486A (da) 1987-04-03
KR890001236B1 (ko) 1989-04-28
DK166343B (da) 1993-04-13
IE862599L (en) 1987-04-02
ATE49121T1 (de) 1990-01-15
DK468486D0 (da) 1986-10-01
AU6342186A (en) 1987-04-09
PT83472B (pt) 1989-05-31
DE3667914D1 (de) 1990-02-08
ZA867494B (en) 1988-05-25
NZ217778A (en) 1989-03-29
PT83472A (en) 1986-11-01

Similar Documents

Publication Publication Date Title
IT1209667B (it) Composizione effeverscente adattivita' analgesica.
ZA856905B (en) Expectorant
IT8522425A0 (it) Procedimento di sintesi dell'amikacina.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
IT8719048A0 (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
PT81933A (en) Process for preparing improved antiinflammatory compositions containing pyroxicam and inositol
PL270981A1 (en) Pesticide containing novel derivatives of 2-phenylimidazole
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
FI860247A0 (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
NO870834L (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
PH24057A (en) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-ene derivatives,pharmaceutical composition containing said compounds and method of use thereof
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
DK310685A (da) 5,6-dihydro-4h-cyklopenta(b)-tiofen-6-karboxylsyrer, fremgangsmaadetil fremstilling af dem og laegemiddelpraeparat indeholdende dem
JPS6416755A (en) Manufacture of n-(3',4'-dimethoxycinnamoyl)-aniline derivative
AU1517788A (en) Analogs of (1,7-DI-Alanine, des-19-leucine)
FR2583416B1 (fr) Composition d'aminobenzylamines.
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
AU8146887A (en) N (halobenzoyl)n'(4-cf3-f-phenyl)- ureas & - thioureas
FI893001A0 (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1,2-bensisoxazol-3-yl- och 1,2-bensisotiazol -3-ylderivat.
ATE70840T1 (de) Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
FI940103A (fi) 2',3'-deoksi-2',3'-didehydronukleosidien valmistus
ATE53214T1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IT208775Z2 (it) Siringa per l'anestesia intraligamentosa.
IT8422148A0 (it) Procedimento per la preparazione dell'hopantenato di calcio.

Legal Events

Date Code Title Description
PBP Patent lapsed